178 related articles for article (PubMed ID: 29107217)
1. Ultrasensitive MRI detection of spontaneous pancreatic tumors with nanocage-based targeted contrast agent.
Kawano T; Murata M; Kang JH; Piao JS; Narahara S; Hyodo F; Hamano N; Guo J; Oguri S; Ohuchida K; Hashizume M
Biomaterials; 2018 Jan; 152():37-46. PubMed ID: 29107217
[TBL] [Abstract][Full Text] [Related]
2. Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1.
Murata M; Narahara S; Kawano T; Hamano N; Piao JS; Kang JH; Ohuchida K; Murakami T; Hashizume M
Mol Pharm; 2015 May; 12(5):1422-30. PubMed ID: 25811429
[TBL] [Abstract][Full Text] [Related]
3. A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer.
Wang Q; Yan H; Jin Y; Wang Z; Huang W; Qiu J; Kang F; Wang K; Zhao X; Tian J
Biomaterials; 2018 Nov; 183():173-184. PubMed ID: 30172243
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembled Nanomicelles as MRI Blood-Pool Contrast Agent.
Babič A; Vorobiev V; Xayaphoummine C; Lapicorey G; Chauvin AS; Helm L; Allémann E
Chemistry; 2018 Jan; 24(6):1348-1357. PubMed ID: 29120077
[TBL] [Abstract][Full Text] [Related]
5. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR
Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450
[TBL] [Abstract][Full Text] [Related]
6. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
7. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
8. Glypican-1-antibody-conjugated Gd-Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer.
Huang X; Fan C; Zhu H; Le W; Cui S; Chen X; Li W; Zhang F; Huang Y; Sh D; Cui Z; Shao C; Chen B
Int J Nanomedicine; 2018; 13():2585-2599. PubMed ID: 29750031
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Targeted and Clearable Human Protein-Based MRI Nanoprobes.
Zhao Y; Peng J; Li J; Huang L; Yang J; Huang K; Li H; Jiang N; Zheng S; Zhang X; Niu Y; Han G
Nano Lett; 2017 Jul; 17(7):4096-4100. PubMed ID: 28581764
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
11. Gd(III)-Dithiolane Gold Nanoparticles for T1-Weighted Magnetic Resonance Imaging of the Pancreas.
Holbrook RJ; Rammohan N; Rotz MW; MacRenaris KW; Preslar AT; Meade TJ
Nano Lett; 2016 May; 16(5):3202-9. PubMed ID: 27050622
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
13. High-relaxivity MRI contrast agents prepared from miniemulsion polymerization using gadolinium(III)-based metallosurfactants.
Gong P; Chen Z; Chen Y; Wang W; Wang X; Hu A
Chem Commun (Camb); 2011 Apr; 47(14):4240-2. PubMed ID: 21359276
[TBL] [Abstract][Full Text] [Related]
14. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
15. Facile Synthesis of Gadolinium Chelate-Conjugated Polymer Nanoparticles for Fluorescence/Magnetic Resonance Dual-Modal Imaging.
Pan Y; Chen W; Yang J; Zheng J; Yang M; Yi C
Anal Chem; 2018 Feb; 90(3):1992-2000. PubMed ID: 29293314
[TBL] [Abstract][Full Text] [Related]
16. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
[TBL] [Abstract][Full Text] [Related]
17. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
[TBL] [Abstract][Full Text] [Related]
18. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
[TBL] [Abstract][Full Text] [Related]
19. A novel cholic acid-based contrast enhancement agent for targeted MRI.
Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
[TBL] [Abstract][Full Text] [Related]
20. Ratiometric MRI sensors based on core-shell nanoparticles for quantitative pH imaging.
Okada S; Mizukami S; Sakata T; Matsumura Y; Yoshioka Y; Kikuchi K
Adv Mater; 2014 May; 26(19):2989-92. PubMed ID: 24453039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
